Illustration of adalimumab (marketed under the name Humira), a monoclonal antibody for treating arthritis, psoriasis, Crohns disease, and ulcerative colitis. Adalimumab is an immunosuppressant that works by inhibiting tumour necrosis factor-alpha (TNF-alpha, dark purple).
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG35143112
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
humiraadalimumabantibodyimmunosuppressiveautoimmunediseasesarthritisrheumatoidcrohnsdiseaseulcerativecolitispsoriasisbiologicaltherapeuticspharmaceuticaldrugdevelopmentproteinstructurehealthcaremedicinemedicalpharmacologydrugpharmacological3dthreedimensionalnobodyno-onemoleculemolecularmodelmolecularstructureartworkillustrationbiochemistrybiochemicalbiologybiologicalcgidigitally-generated
3dadalimumabantibodyarthritisartworkautoimmunebiochemicalbiochemistrybiologicalbiologicalbiologycgicolitiscrohnsdevelopmentdigitally-generateddimensionaldiseasediseasesdrugdrughealthcarehumiraillustrationimmunosuppressivemedicalmedicinemodelmolecularmolecularmoleculeno-onenobodypharmaceuticalpharmacologicalpharmacologyproteinpsoriasisrheumatoidstructurestructuretherapeuticsthreeulcerative
Loading